SCHEMBL29353166

SCHEMBL29353166

c1cnc2c(O[Ga](Oc3cccc4cccnc34)Oc3cccc4cccnc34)cccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.56
LMNA P02545 5/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
MAPT P10636 5/20 0.55
RAB9A P51151 6/20 0.55
NPC1 O15118 5/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
HSP90AA1 P07900 2/20 0.54
CYP3A4 P08684 2/20 0.52
MMP2 P08253 2/20 0.52
TSHR P16473 2/20 0.52
GMNN O75496 1/20 0.52
TP53 P04637 1/20 0.52
CYP2D6 P10635 1/20 0.52
MMP9 P14780 1/20 0.52
ALOX15 P16050 1/20 0.52
NFKB1 P19838 1/20 0.52
MMP8 P22894 1/20 0.52
CCR1 P32246 1/20 0.52
THPO P40225 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28727740 1.00 KDM4E (0.56) KDM4ELMNASMN1; SMN2MAPTRAB9A
SCHEMBL4386263 0.81 KDM4E (0.72) KDM4ELMNASMN1; SMN2MAPTRAB9A
SCHEMBL27485989 0.80 KDM4E (0.56) KDM4ELMNASMN1; SMN2MAPTRAB9A
Hydrochloric Acid SCHEMBL27496748 0.79 KDM4E (0.59) KDM4ELMNASMN1; SMN2MAPTRAB9A
SCHEMBL27919535 0.78 LMNA (0.63) KDM4ELMNASMN1; SMN2MAPTRAB9A
SCHEMBL250695 0.78 KDM4E (0.54) KDM4ELMNASMN1; SMN2MAPTRAB9A
SCHEMBL1878470 0.78 KDM4E (0.58) KDM4ELMNASMN1; SMN2MAPTRAB9A
SCHEMBL6516869 0.78 KDM4E (0.58) KDM4ELMNASMN1; SMN2MAPTRAB9A
SCHEMBL17924042 0.78 MAPT (0.59) KDM4ELMNASMN1; SMN2MAPTRAB9A
SCHEMBL21753772 0.78 KDM4E (0.58) KDM4ELMNASMN1; SMN2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 358 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260033233-A1 SEMICONDUCTOR NANOPARTICLE, PRODUCTION METHOD THEREOF,ELECTROLUMINESCENT DEVICE, PRODUCTION METHOD THEREOF, AND DISPLAY INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2026-01-29 US claimed
EP-4685207-A1 SEMICONDUCTOR NANOPARTICLE, PRODUCTION METHOD THEREOF, ELECTROLUMINESCENT DEVICE, PRODUCTION METHOD THEREOF, AND DISPLAY INCLUDING THE SAME Samsung Electronics Co., Ltd. (KR) 2026-01-28 EP claimed
EP-3582778-B1 COMPOSITIONS OF GALLIUM (III) COMPLEXES FOR ORAL ADMINISTRATION MEDMELIOR INC (CA) 2022-10-05 EP claimed
EP-3537492-B1 QUANTUM DOT DEVICE AND ELECTRONIC DEVICE SAMSUNG ELECTRONICS CO LTD (KR) 2022-04-27 EP claimed
US-12635315-B2 Nanostructures, production method thereof, electronic device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-05-19 US disclosed
US-20260135621-A1 APPARATUS AND METHOD FOR OPTICAL COMMUNICATION USING ORGANIC PHOTOELECTRIC CONVERSION DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-05-14 US disclosed
US-12628494-B2 Semiconductor nanoparticle with high level of circularity and electroluminescent device including same SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-05-12 US disclosed
US-20260125597-A1 SEMICONDUCTOR NANOPARTICLE, METHOD OF PRODUCING THE SAME AND ELECTRONIC DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2026-05-07 US disclosed
US-12612378-B2 Compound, photoelectric device, light absorption sensor, sensor-embedded display panel, and electronic device SAMSUNG DISPLAY CO., LTD. (KR) 2026-04-28 US disclosed
US-20260104302-A1 STRETCHABLE PANEL AND ELECTRONIC DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-04-16 US disclosed
EP-4506995-B1 METHOD FOR MANUFACTURING A COLOR-CONVERTING OPTOELECTRONIC DEVICE, COMPRISING A STEP OF OPTICALLY FORMING SURFACE POTENTIAL PATTERNS IN AN ELECTRET LAYER COMMISSARIAT ENERGIE ATOMIQUE (FR) 2026-04-15 EP disclosed
EP-3985083-B1 QUANTUM DOTS AND DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2026-04-01 EP disclosed
US-11251390-B2 Light emitting device and display device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-02-15 US disclosed
US-20220041930-A1 QUANTUM DOTS AND DEVICES INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-02-10 US disclosed
US-20220041628-A1 ORGANIC COMPOUND, ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-02-10 US disclosed
EP-3472249-B1 FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL MERCK PATENT GMBH (DE) 2022-02-02 EP disclosed
CN-107026237-B Optoelectronic device, and image sensor and electronic device including the same 三星电子株式会社 2022-01-28 CN disclosed
US-20220025256-A1 QUANTUM DOTS, QUANTUM DOT-POLYMER COMPOSITE, AND ELECTRONIC DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-01-27 US disclosed
EP-3943574-A1 QUANTUM DOTS, QUANTUM DOT-POLYMER COMPOSITE, AND ELECTRONIC DEVICE INCLUDING THE SAME Samsung Electronics Co., Ltd. (KR) 2022-01-26 EP disclosed
CN-113969165-A Quantum dot, and quantum dot-polymer composite and electronic device including the same 三星电子株式会社 2022-01-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260033233-A1 SEMICONDUCTOR NANOPARTICLE, PRODUCTION METHOD THEREOF,ELECTROLUMINESCENT DEVICE, PRODUCTION METHOD THEREOF, AND DISPLAY INCLUDING THE SAME TRPA1, SELENOI, ZKSCAN2 KDM4E 1122/4885LMNA 4589/4885SMN1; SMN2 400/4885
US-20260125597-A1 SEMICONDUCTOR NANOPARTICLE, METHOD OF PRODUCING THE SAME AND ELECTRONIC DEVICE INCLUDING THE SAME L1CAM, SOD1, SOD3 KDM4E 2220/4885LMNA 3881/4885SMN1; SMN2 13/4885
US-20260104302-A1 STRETCHABLE PANEL AND ELECTRONIC DEVICE PIEZO1, SMCHD1, MEF2D KDM4E 714/4885LMNA 2078/4885SMN1; SMN2 576/4885
US-12635315-B2 Nanostructures, production method thereof, electronic device including the same SOD1, SOD3, SCLY KDM4E 1512/4885LMNA 3915/4885SMN1; SMN2 209/4885
US-20220041628-A1 ORGANIC COMPOUND, ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE OR10J3, OR51E2, ORC3 KDM4E 1789/4885LMNA 4223/4885SMN1; SMN2 4832/4885
US-12612378-B2 Compound, photoelectric device, light absorption sensor, sensor-embedded display panel, and electronic device NR2E3, GRK1, CRY1 KDM4E 1801/4885LMNA 2785/4885SMN1; SMN2 3793/4885
US-12628494-B2 Semiconductor nanoparticle with high level of circularity and electroluminescent device including same SOD1, SLC39A3, SLC39A7 KDM4E 2596/4885LMNA 2926/4885SMN1; SMN2 773/4885
US-20260135621-A1 APPARATUS AND METHOD FOR OPTICAL COMMUNICATION USING ORGANIC PHOTOELECTRIC CONVERSION DEVICE CTNND1, OR10J3, CDH1 KDM4E 2340/4885LMNA 3037/4885SMN1; SMN2 3396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.